#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Uveal melanoma Desmoid tumour Emphysema Wiskott-Aldrich syndrome Round cell liposarcoma Factor IX deficiency Bronchiolitis Plasma cell myeloma recurrent Insulinoma Thromboangiitis obliterans Polycythaemia vera Pleomorphic liposarcoma Anti-glomerular basement membrane disease Encephalopathy neonatal Acute graft versus host disease in skin More trials…

    Learn about Rare Diseases

    Haemophilia A without inhibitors Medulloblastoma recurrent – Treatment Mitochondrial myopathy – Trials in Disease Haemophilia A without inhibitors – Diagnostics Ewing’s sarcoma – Treatment Mucopolysaccharidosis – Trials in Disease Hereditary motor and sensory neuropathy – Basic Information Hereditary motor and sensory neuropathy – Diagnostics Loeys-Dietz syndrome – Trials in Disease Prader-Willi syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vinflunine LIPASE Potassium Iodide Gen1047 Amoxicillin Vesleteplirsen Tropicamide Naloxegol Oxalate ARTICAINE HYDROCHLORIDE Valproate Semisodium Ontasameran Eftrenonacog Alfa Metolazone Oxytocin Synthetic SAROGLITAZAR HEMIMAGNESIUM Beclometasone Dipropionate ARGININE GLUTAMATE Azd5492 Bms-986458 Vanglusagene Ensiparvovec More therapies…

    Learn about Your Condition

    Ocular hypertension Colorectal adenoma Thrombosis prophylaxis Malignant peritoneal neoplasm Haematological malignancy Antithrombin III deficiency Femoral hernia Myeloproliferative neoplasm Transferrin decreased Peyronie's disease Rectal cancer stage III Pneumonia chlamydial Aortic stenosis Endocarditis Rabies More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn’s disease

    Recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Duvakitug
    Austria Belgium Bulgaria Czechia France Germany +9

  • A study to evaluate the safety and effectiveness of tafasitamab in adults with autoimmune thrombocytopenia or autoimmune hemolytic anemia

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Autoimmune haemolytic anaemia
    • Immune thrombocytopenia
    Investigated Drugs:
    • Tafasitamab
    France Italy The Netherlands Spain

  • A study comparing the effectiveness and safety of datopotamab deruxtecan and docetaxel in adults with advanced or metastatic non-squamous non-small cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Datopotamab Deruxtecan
    • Docetaxel
    Austria Belgium France Germany Hungary Italy +2

  • A study to evaluate the safety and effectiveness of BNT324 and BNT327 in patients with advanced lung cancer

    Recruiting

    1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    • Non-small cell lung cancer metastatic
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • BNT327
    France Italy Poland Spain

  • A study of etentamig and daratumumab compared to daratumumab, lenalidomide, and dexamethasone in adults with newly diagnosed multiple myeloma not eligible for transplant

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Daratumumab
    • Dexamethasone
    • Lenalidomide
    France Norway Spain

  • A study to evaluate the safety and effects of inebilizumab in children and adolescents with immunoglobulin G4-related disease

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Inebilizumab
    Greece Italy Poland Spain
Previous Page
1 … 57 58 59 60 61 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!